000			02180 a2200589 4500
005			20250516234220.0
264		0	_c20150623
008			201506s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0107455 _2doi
040			_aNLM _beng _cNLM
100	1		_aFennell, Dean A
245	0	0	_aAssociation between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II study. _h[electronic resource]
260			_bPloS one _c2014
300			_ae107455 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aCluster Analysis
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGlutamates _xadministration & dosage
650	0	4	_aGuanine _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOligonucleotide Array Sequence Analysis
650	0	4	_aOutcome Assessment, Health Care _xmethods
650	0	4	_aPemetrexed
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aThymidylate Synthase _xgenetics
650	0	4	_aTranscriptome _xdrug effects
700	1		_aMyrand, Scott P
700	1		_aNguyen, Tuan S
700	1		_aFerry, David
700	1		_aKerr, Keith M
700	1		_aMaxwell, Perry
700	1		_aMoore, Stephen D
700	1		_aVisseren-Grul, Carla
700	1		_aDas, Mayukh
700	1		_aNicolson, Marianne C
773	0		_tPloS one _gvol. 9 _gno. 9 _gp. e107455
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0107455 _zAvailable from publisher's website
999			_c24217713 _d24217713